Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00714441 · ClinicalTrials.gov registry record · NA
Reducing Distress and Improving Self-Care in Diabetes
A NA study of Diabetes Type 2, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 392
- Enrollment target
- 1
- Study location
NCT00714441: Completed NA study of Diabetes Type 2, sponsored by University of California, San Francisco.
NCT00714441 is a NA study of Diabetes Type 2 that has completed, run by University of California, San Francisco. The registered enrollment target is 392 participants, below the 651-participant average among 24 other Diabetes Type 2 trials with a reported enrollment target (40% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00714441, a NA study of Diabetes Type 2, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 392 participants
- Enrollment target
- 1
- Study location
Study Summary
To date, there have been few practical, evidenced based interventions that are directed at patients with Type II Diabetes who are experiencing depressed and/or emotional distress in primary care settings. This study will (1) combine two existing, evidenced-based, interventions (a computer automated, diabetes specific self-management program (CASM) vs. a self-care program plus a live problem solving distress-reduction program (CAPS) vs. a lifestyle and activities education program (LEAP-AHEAD)) into a practical, 3-arm clinical trial with a highly distressed multi-ethnic patient sample, and (2) evaluate the intervention using the RE-AIM framework, sharing the results through a comprehensive dissemination package. Hypothesis 1: The combined CASM and CAPS arms will be superior to the LEAP-AHEAD group on the primary outcomes at follow-up. Hypothesis 2: The CAPS arm will be superior to the CASM arm on primary outcomes at follow-up.
Conditions Studied
Interventions
- BEHAVIORAL Lifestyle and Activities Education Program (LEAP-AHEAD)
- BEHAVIORAL Computer Automated Self-Management (CASM)
- BEHAVIORAL Computer Automated Self-Management and Problem Solving Therapy (CAPS)
Study Locations (1)
California
- UC San Francisco, Family and Community Medicine Dept. - San Francisco
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 392 participants |
| Start Date | 2008-07 |
| Est. Completion | 2011-11 |
| Phase | NA |
What the finished NCT00714441 record still lists
NCT00714441 is an interventional study that assigns participants to a tested intervention. The registered 392 participants enrollment target is mid-sized for trials with a published cap, below the 651-participant average among 24 other Diabetes Type 2 trials with a reported enrollment target (40% lower).
The record links to 1 condition, with Diabetes Type 2 appearing as the primary indexed condition, and to 3 interventions - of which Lifestyle and Activities Education Program (LEAP-AHEAD) is the first listed.
NCT00714441 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00714441 about?
NCT00714441 is a clinical study titled "Reducing Distress and Improving Self-Care in Diabetes". To date, there have been few practical, evidenced based interventions that are directed at patients with Type II Diabetes who are experiencing depressed and/or emotional distress in primary care settings. This study will (1) combine two existing, evidenced-based, interventions (a computer automated,...
What is the current status of trial NCT00714441?
This trial is currently completed. It is a NA study. The enrollment target is 392 participants. The study started on 2008-07. Estimated completion is 2011-11.
What conditions does trial NCT00714441 study?
This clinical trial studies the following conditions: Diabetes Type 2.
What interventions are being tested in trial NCT00714441?
The interventions under investigation include: Lifestyle and Activities Education Program (LEAP-AHEAD) (BEHAVIORAL), Computer Automated Self-Management (CASM) (BEHAVIORAL), Computer Automated Self-Management and Problem Solving Therapy (CAPS) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00714441?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00714441 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Type 2
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00714441's enrollment target sits among peer trials
392 7th of 24 higher than 18 of 24 other Diabetes Type 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Harnessing Macrophage Lysosomal Lipid Metabolism in Obesity
RECRUITING · NA
-
Dulce Digital 2.0 - Innovative Diabetes Self-Management in the Digital Age
RECRUITING · NA
-
Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes
RECRUITING · NA
-
FELLAShip to Better Health
RECRUITING · NA
-
Healthy Living Anson Study
RECRUITING · NA
-
Pilot of Continuous Glucose Monitor-Augmented Food Is Medicine
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06397703 · 392 participants · Phase 2
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
- NCT06625775 · 392 participants · Phase 1
Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- NCT07220967 · 392 participants · Phase 4
A Study of Antibiotic Delivery to Prevent Infection After Breast Tissue Expander Placement
- NCT07290036 · 392 participants · Phase 1
A Study to Learn if Bimekizumab Given in Different Ways is Safe and Moves Similarly Throughout the Body Over Time in Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia